Fulgent Genetics, Inc.
Company Information
Industry Services-Medical Laboratories
SIC Code 8071
Entity Type operating
SEC Category Accelerated filer
State of Incorporation DE
Business Address 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
Mailing Address 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
Phone 626-350-0537
Fiscal Year End 1231
EIN 812621304
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 17, 2026 | View on SEC |
| 4 Insider stock transaction report | March 11, 2026 | View on SEC |
| 4 Insider stock transaction report | March 2, 2026 | View on SEC |
| 4 Insider stock transaction report | March 2, 2026 | View on SEC |
| 4 Insider stock transaction report | March 2, 2026 | View on SEC |
| 4 Insider stock transaction report | March 2, 2026 | View on SEC |
| 8-K Current report of material events | February 27, 2026 | View on SEC |
| 10-K Annual financial report | February 27, 2026 | View on SEC |
| 4 Insider stock transaction report | February 25, 2026 | View on SEC |
| 4 Insider stock transaction report | February 25, 2026 | View on SEC |
Annual Reports
10-K February 27, 2026
- Specializes in comprehensive genetic testing and precision medicine solutions.
- Offers a broad range of genetic tests for inherited diseases, cancer, and reproductive health.
Material Events
8-K Acquisition March 17, 2026
High Impact
- Fulgent Genetics diversifies revenue and expands into broader diagnostic markets (dermatopathology, podiatric pathology).
- Acquired specialized businesses (StrataDx, Bakotic assets) with existing customer bases and expert teams.
Insider Trading
SELL 2 insiders
7 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 8071)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.